Children’s Memorial Health Institute
Anna Tylki-Szymańska is Professor of Paediatrics and Metabolic Medicine at the Children’s Memorial Health Institute, Department of Metabolic Diseases in Warsaw, Poland. She obtained her medical degree from the Warsaw Medical University and received postgraduate training at the department of Genetics of the Hôpital Necker-Enfant Malade in Paris. After receiving her doctorate she trained at various centers in London, Lyon, Paris, and in New York.
In the field of metabolic diseases, Professor Tylki-Szymańska’s main focus lies in lysosomal diseases, an area in which she has over 30 years’ experience at the Children’s Memorial Health Institute in Warsaw.
Professor Tylki-Szymańska’s research interests are directed in particular on neurometabolic and neurodevelopmental diseases, and is especially interested in developing diagnostic assays and new approaches for the treatment of lysosomal diseases.
She was a principal investigator for the recombinant enzyme replacement clinical trials for Gaucher, Fabry, MPS II (Hunter syndrome or mucopolysaccharidosis II) and substrate inhibition therapy trials for MPS III and Gaucher disease. She is the author of numerous scientific papers in leading international journals. Professor Tylki-Szymańska is a winner of the Order of the Smile, an international award given by children to adults distinguished in their love, care and aid for children.
Shaare Zedek Medical Center
Ari Zimran is Director of the Gaucher Clinic at Shaare Zedek Medical Center in Jerusalem, Israel, which is the world’s largest referral clinic for Gaucher disease. Professor Zimran is also Associate Professor of Medicine at the Hebrew University Hadassah Medical School.
He is the author or co-author of more than 260 professional papers and reviews, and has edited three books, the latest one, together with Professor Tony Futerman, is one of the most comprehensive and up-to-date textbooks dedicated to Gaucher disease.
Professor Zimran has been a leader in clinical trials with investigative drugs for Gaucher disease. As a mentor in the academic context, Professor Zimran has supervised many dozens of medical students and young doctors in basic research and clinical studies. He is also on the Executive Committee of GOS (Gaucher Disease Outcome Survey).
Royal Free Hospital and Professor, University College London
Atul Mehta is a Consultant Haematologist and Physician at the Royal Free Hospital in London, UK. He is also Clinical Director of the Lysosomal Storage Disorders (LSD) Unit at the hospital, and works with a team of nurses, physicians and researchers to develop and deliver care to patients and families with LSDs.
Professor Mehta completed his undergraduate training at Cambridge University and King’s College Hospital and then trained in general internal medicine at King’s College Hospital and Hammersmith Hospital in London, and in haematology at the Hammersmith Hospital. His doctorate in medicine was sponsored by the Medical Research Council and he spent 2 years examining molecular mechanisms underlying aplastic anaemia at Imperial College, London.
Professor Mehta is a senior examiner in haematology and medicine at the University of London, is the author of three books, and has more than 40 chapters and over 200 publications in peer-reviewed journals.